Tejas Networks (TEJASNET)

Turnaround

FairStock Score: 25/100 — RISKY

Score breakdown: P/E: 0/3 · ROCE: 1/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Current Price₹538.5
Market Cap₹9,571.43 Cr
P/E Ratio0
ROCE15.47%
ROE-20%
Dividend Yield0.42%
Profit Growth-218.64%
Debt/Equity1.43
Sales Growth99.1%
Free Cash Flow₹-1,146.7 Cr
Promoter Holding53.46%
52-Week Range₹294 — ₹644.75
SectorTelecom - Equipment & Accessories
Book Value₹164.9

Strengths

Concerns

AI Analysis

Tejas Networks fails my first test: it doesn't earn money. For the latest quarter, sales were ₹307 Cr but net profit was minus ₹197 Cr. Full-year profit growth is -218.64%, with sales down 18.26%. A zero P/E means no earnings to base a valuation on; Graham would ignore any number that gives false precision. Free cash flow is -₹1,147 Cr, so the business is consuming cash, not generating it. ROE is -20%, which destroys shareholder value. ROCE of 15.47% at least suggests the core operations create some return on capital, but I need to see this line actually reach the bottom line before calling it good. From these numbers, I cannot identify a durable moat either; a business that cannot generate consistent profits has no proven competitive edge. The financial health is worrying. Altman Z-score of 0.92 puts the company in the distress zone, and the Piotroski F-score of 3/9 reinforces that. Debt/equity of 0.89 is not extreme, but when cash flow is deeply negative, high debt becomes heavier. Book value per share is ₹216.57, and at ₹402.15 the stock trades at 1.86 times book. That is not a margin of safety for a loss-making company; it is a premium for uncertainty. The 52-week range from ₹294 to ₹647 shows how volatile this can be, and buying after a fall is not the same as buying value. Promoter holding of 53.46% does align interests, and the 0.57% dividend gives pennies while shareholders take the risk. I prefer a wonderful business at a fair price, and this is a challenged business at an unjustifiable price. I would watch for an actual turnaround in sales and operating cash flow before considering it. Until then, this is not a compounder; it is a speculation. The only rational category for a patient value investor is a possible turnaround, but only after proof arrives.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer